Carlsmed Q1 EPS $(0.32) Beats $(0.41) Estimate, Sales $16.100M Beat $14.984M Estimate

Benzinga Newsdesk www.benzinga.com Negative 96.1%

Neg 96.1% Neu 0% Pos 0%

Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.41) by 21.95 percent. The company reported quarterly sales of $16.100 million which beat the analyst consensus estimate of $14.984 million by 7.45 percent.